A TCW Group Inc.-backed special purpose acquisition corporation, which raised $465 million last month, has named a software and biotech expert to its advisory board.
TCW is an investment management firm with about $248 billion of assets under management.
The TCW SPAC, which is targeting the tech, health care, industrial and consumer sectors, named Nanxi Liu to its advisory board this week.
Liu is co-founder and chief executive of Culver City-based Enplug, a digital signage software business. She previously co-founded Nanoly Bioscience Inc., a Denver-based venture-backed biotech company that develops polymers that eliminate the need for refrigeration for vaccines and therapeutics.